As Albert Einstein said, “All that is valuable in human society depends upon the opportunity for development”, and this is precisely the case of genetics and molecular biology applied to medicine.
The new technologies, always more sensitive and advanced, allowed the achievement of unimaginable results.
With the opening of the new division OncoNextTM, and in particular with the launch of OncoNext LiquidTM, Genoma Group not only will raise the chance of curing oncologic patients, but will offer the possibility of an early diagnosis to all high risk people.
We are glad to be part of this new technological and scientific era because progress brings the prospect of a better future.
The executive director and Genoma Group CEO